Thu, August 6, 2009
Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Sat, August 1, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Sat, July 25, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Sun, July 19, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009
Mon, July 13, 2009
Fri, July 10, 2009
Thu, July 9, 2009
Wed, July 8, 2009
Tue, July 7, 2009
Mon, July 6, 2009
Fri, July 3, 2009
Thu, July 2, 2009
Wed, July 1, 2009
Tue, June 30, 2009
Mon, June 29, 2009
Fri, June 26, 2009
Thu, June 25, 2009
Wed, June 24, 2009
Tue, June 23, 2009
Mon, June 22, 2009
Sun, June 21, 2009
Fri, June 19, 2009
Thu, June 18, 2009
Wed, June 17, 2009
Tue, June 16, 2009
Mon, June 15, 2009
Fri, June 12, 2009
Thu, June 11, 2009
Wed, June 10, 2009
Tue, June 9, 2009
Mon, June 8, 2009
Sun, June 7, 2009
Fri, June 5, 2009
Thu, June 4, 2009
Wed, June 3, 2009
Tue, June 2, 2009

IDenta Corp.: International Drug and Explosives Detection Firm IDenta Corp. Announces First Placement of New General Screening


  Copy link into your clipboard //health-fitness.news-articles.net/content/2009/ .. es-first-placement-of-new-general-screening.html
  Print publication without navigation Published in Health and Fitness on , Last Modified on 2009-07-09 10:11:25 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

JERUSALEM--(Marketwire - July 9, 2009) - IDenta Corp. (PINKSHEETS: [ IDTA ]) announced today that the first placement (3000 units) of the New General Screening Drug Test Kit will be in the pharmacies in Athens, Greece and will happen in a matter of days. IDenta also expects to have orders in the very near future for the New General Screening Drug Test Kit from France, Portugal, USA, India and other markets.

CEO Yaacov Shoham states, "The response to this new test kit has been overwhelming and to already have it on the shelves of some stores after announcing it in February shows the interest that has been generated by this all inclusive kit."

The new General Screening Drug Test Kit features the high standards of IDenta's different products: No false positives, easy to use, reliable, safe, works on trace amounts, inexpensive, environmentally green.

This new kit is currently being manufactured and is intended for law enforcement agencies, but is especially directed to the retail-consumer market (worried parents, schools, working place, etc.).

This one kit will give a positive response for the following 19 types of known drugs: Heroin, Cocaine/Crack, Methamphetamine, Amphetamine, MDMA, Ephedrine, LSD, Methadone, Ketamine, PCP, Pentazocine, Propoxyphene, PMA, Oxycodone, AMT, DMT, Mescaline, Pethidine.

The use of it is very simple, breaking only up to 2 ampoules, and getting the positive color that will indicate the presence of one of the mentioned illicit drugs.

No positive color developed after the two broken ampoules, absolutely no illicit drug is present.

The chemical composition for the new detector is novel and unique.

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at [ www.IDenta.biz ] or [ fpi@drugsdetector.com ]

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, [ fpi@drugsdetector.com ], [ www.identa.biz ].


Publication Contributing Sources

Similar Health and Fitness Publications